To improve survival and quality of life for children and families impacted by childhood cancer and blood diseases by supporting world-class clinical care, funding groundbreaking research, and training the next generation of pediatric hematology/oncology specialists in partnership with the Division of Pediatric Hematology and Oncology at NewYork-Presbyterian/Weill Cornell Medical Center.
Children's Cancer and Blood Foundation Inc centers its giving on one institutional partner: New York Presbyterian Hospital’s Division of Pediatric Hematology and Oncology at NewYork-Presbyterian/Weill Cornell Medical Center. The foundation’s recent awards support treatment and research for childhood blood disorders and cancers, along with clinical care, physician training, survivorship services, and fertility preservation. Its stated purpose is to improve survival and quality of life for children and families affected by childhood cancer and blood diseases through world-class clinical care, groundbreaking research, and training for the next generation of pediatric hematology/oncology specialists. The latest grants on file show continued support for the same medical setting in New York City, with funding directed to the hospital for the care of children with cancer and blood disorders. That consistency is reinforced by the foundation’s active grant programs, which all point back to pediatric hematology-oncology at NewYork-Presbyterian/Weill Cornell and include support for specialty training, research projects, and long-term survivorship care. The grantmaker works through a highly focused model rather than a broad portfolio of unrelated causes.
The foundation’s core program area is pediatric hematology-oncology care. It gives to the Division of Pediatric Hematology and Oncology at NewYork-Presbyterian/Weill Cornell Medical Center for clinical care, research, survivorship programs, and fertility preservation. Physician training is another named priority, with support for specialty training and fellowships tied to the same division. Its active grant programs also include pediatric cancer research and pediatric blood disease research, linking clinical service with research at the same institution. Survivorship care appears as a separate funding theme, showing attention to long-term needs after treatment. Fertility preservation is also part of the support package, alongside direct patient care and clinical patient support services.
The reported grant-size distribution is large: the 25th percentile is $622,513, the median is $823,026, and the 75th percentile is $1,023,540. The recent grants list shows repeat support to the same recipient across 2023 and 2024, indicating an ongoing relationship rather than one-off awards. The foundation is an operating grantmaker with a local geographic scope, and it does not fund individuals or make program-related investments. Its unsolicited-application status is not indicated in the data for the main grants, while the active program entries shown are not open to unsolicited requests.
$109K
$2.2M
$179K
$237K
Most grants fall between $623K and $1M, with a median of $823K.
25th Percentile
$623K
Median
$823K
75th Percentile
$1M
LES LIEBERMAN
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Giving is concentrated entirely in New York: 100% of grants go to recipients in the headquarters state, and New York is also the top state by grant count. The recipient locations in the recent grants list are New York, NY and New York City, both pointing to the same local medical ecosystem. The grantmaker’s geographic reach is therefore local rather than national or international, with all recorded recipient country distribution in the United States.
Its stated purpose is to improve survival and quality of life for children and families affected by childhood cancer and blood diseases. The focus areas include pediatric cancer, pediatric blood disorders, clinical care support, medical research, physician training, survivorship care, and fertility preservation.
The foundation gives to NewYork-Presbyterian/Weill Cornell Medical Center and its Division of Pediatric Hematology and Oncology. The recent grant record also shows support to New York Presbyterian Hospital for treatment and research for childhood blood disorders and cancers.
The typical grant size is substantial: the 25th percentile is $622,513, the median is $823,026, and the 75th percentile is $1,023,540. The recent awards on file include $1,224,053 in 2023 and $422,000 in 2024 to New York Presbyterian Hospital.
No grants in the provided data go outside New York. The geographic scope is local, 100% of grants go to recipients in New York state, and the recipient country distribution is entirely U.S.-based.
It does not fund individuals. The active grant programs described are tied to the Division of Pediatric Hematology and Oncology at NewYork-Presbyterian/Weill Cornell, and the main program entries shown do not indicate an open unsolicited application process.
2025
Source: IRS Form 990-PF, fiscal year 2025.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| NEW YORK PRESBYTERIAN HOSPITAL | NEW YORK, NY | $108,520 | 2025 | TREATMENT AND RESEARCH FOR CHILDHOOD BLOOD DISORDERS AND CANCERS |
| NEW YORK PRESBYTERIAN HOSPITAL | NEW YORK, NY | $422,000 | 2024 | TREATMENT AND RESEARCH FOR CHILDHOOD BLOOD DISORDERS AND CANCERS |
| NEW YORK PRESBYTERIAN HOSPITAL | NEW YORK, NY | $1,224,053 | 2023 | TREATMENT AND RESEARCH FOR CHILDHOOD BLOOD DISORDERS AND CANCERS |
NEW YORK PRESBYTERIAN HOSPITAL
$108,520TREATMENT AND RESEARCH FOR CHILDHOOD BLOOD DISORDERS AND CANCERS
NEW YORK PRESBYTERIAN HOSPITAL
$422,000TREATMENT AND RESEARCH FOR CHILDHOOD BLOOD DISORDERS AND CANCERS
NEW YORK PRESBYTERIAN HOSPITAL
$1,224,053TREATMENT AND RESEARCH FOR CHILDHOOD BLOOD DISORDERS AND CANCERS